Literature DB >> 10456882

Down-regulation of Th2 responses by Brucella abortus, a strong Th1 stimulus, correlates with alterations in the B7.2-CD28 pathway.

I Agranovich1, D E Scott, D Terle, K Lee, B Golding.   

Abstract

Down-regulation of the Th2-like response induced by ovalbumin-alum (OVA/alum) immunization by heat-killed Brucella abortus was not reversed by anti-IL-12 antibody treatment or in gamma interferon (IFN-gamma) knockout mice, suggesting that induction of Th1 cytokines was not the only mechanism involved in the B. abortus-mediated inhibition of the Th2 response to OVA/alum. The focus of this study was to determine whether an alternative pathway involves alteration in expression of costimulatory molecules. First we show that the Th2-like response to OVA/alum is dependent on B7.2 interaction with ligand since it can be abrogated by anti-B7.2 treatment. Expression of costimulatory molecules was then studied in mice immunized with OVA/alum in the absence or presence of B. abortus. B7.2, but not B7.1, was up-regulated on mouse non-T and T cells following immunization with B. abortus. Surprisingly, B. abortus induced down-regulation of CD28 and up-regulation of B7.2 on murine CD4(+) and CD8(+) T cells. These effects on T cells were maximal for CD28 and B7.2 at 40 to 48 h and were not dependent on interleukin-12 (IL-12) or IFN-gamma. On the basis of these results, we propose that the IL-12/IFN-gamma-independent inhibition of Th2 responses to OVA/alum is secondary to the effects of B. abortus on expression of costimulatory molecules on T cells. We suggest that down-regulation of CD28 following activation inhibits subsequent differentiation of Th0 into Th2 cells. In addition, decreased expression of CD28 and increased expression of B7.2 on T cells would favor B7.2 interaction with CTLA-4 on T cells, and this could provide a negative signal to developing Th2 cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10456882      PMCID: PMC96760     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

1.  B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro.

Authors:  D M Sansom; N D Hall
Journal:  Eur J Immunol       Date:  1993-01       Impact factor: 5.532

2.  T-independent responses in B cell-defective CBA/N mice to Brucella abortus and to trinitrophenyl (TNP) conjugates of Brucella abortus.

Authors:  J J Mond; I Scher; D E Mosier; M Baese; W E Paul
Journal:  Eur J Immunol       Date:  1978-07       Impact factor: 5.532

3.  Detection of individual mouse splenic T cells producing IFN-gamma and IL-5 using the enzyme-linked immunospot (ELISPOT) assay.

Authors:  T Taguchi; J R McGhee; R L Coffman; K W Beagley; J H Eldridge; K Takatsu; H Kiyono
Journal:  J Immunol Methods       Date:  1990-03-27       Impact factor: 2.303

4.  Interleukin-7 specifically induces the B7/BB1 antigen on human cord blood and peripheral blood T cells and T cell clones.

Authors:  H Yssel; P V Schneider; L L Lanier
Journal:  Int Immunol       Date:  1993-07       Impact factor: 4.823

5.  Lipopolysaccharide from Brucella abortus behaves as a T-cell-independent type 1 carrier in murine antigen-specific antibody responses.

Authors:  M Betts; P Beining; M Brunswick; J Inman; R D Angus; T Hoffman; B Golding
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

6.  Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression.

Authors:  N Nabavi; G J Freeman; A Gault; D Godfrey; L M Nadler; L H Glimcher
Journal:  Nature       Date:  1992-11-19       Impact factor: 49.962

7.  IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses.

Authors:  F D Finkelman; I M Katona; T R Mosmann; R L Coffman
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

8.  CTLA-4: a negative regulator of autoimmune disease.

Authors:  N J Karandikar; C L Vanderlugt; T L Walunas; S D Miller; J A Bluestone
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

9.  Anti-interferon gamma treatment blocks the ability of glutaraldehyde-polymerized allergens to inhibit specific IgE responses.

Authors:  K T HayGlass; B P Stefura
Journal:  J Exp Med       Date:  1991-02-01       Impact factor: 14.307

10.  Functional expression of B7/BB1 on activated T lymphocytes.

Authors:  M Azuma; H Yssel; J H Phillips; H Spits; L L Lanier
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

View more
  9 in total

1.  Induction of antigen-specific Th1-type immune responses by gamma-irradiated recombinant Brucella abortus RB51.

Authors:  Neelima Sanakkayala; Anna Sokolovska; Jatinder Gulani; Harm Hogenesch; Nammalwar Sriranganathan; Stephen M Boyle; Gerhardt G Schurig; Ramesh Vemulapalli
Journal:  Clin Diagn Lab Immunol       Date:  2005-12

2.  Brucella abortus ΔrpoE1 confers protective immunity against wild type challenge in a mouse model of brucellosis.

Authors:  Jonathan W Willett; Julien Herrou; Daniel M Czyz; Jason X Cheng; Sean Crosson
Journal:  Vaccine       Date:  2016-08-31       Impact factor: 3.641

3.  Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses.

Authors:  R Vemulapalli; Y He; S M Boyle; N Sriranganathan; G G Schurig
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

4.  Recombinant Ochrobactrum anthropi expressing Brucella abortus Cu,Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 type.

Authors:  Yongqun He; Ramesh Vemulapalli; Gerhardt G Schurig
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

5.  CD80/CD28 co-stimulation in human brucellosis.

Authors:  P Skendros; P Boura; F Kamaria; M Raptopoulou-Gigi
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

6.  Inactivation of the type IV secretion system reduces the Th1 polarization of the immune response to Brucella abortus infection.

Authors:  Hortensia García Rolán; Renée M Tsolis
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

7.  Brucella neotomae Recapitulates Attributes of Zoonotic Human Disease in a Murine Infection Model.

Authors:  Yoon-Suk Kang; Daniel A Brown; James E Kirby
Journal:  Infect Immun       Date:  2018-12-19       Impact factor: 3.441

8.  Toll-like receptors are critical for clearance of Brucella and play different roles in development of adaptive immunity following aerosol challenge in mice.

Authors:  Jianwu Pei; Xicheng Ding; Yaping Fan; Allison Rice-Ficht; Thomas A Ficht
Journal:  Front Cell Infect Microbiol       Date:  2012-09-07       Impact factor: 5.293

9.  Lack of endogenous IL-10 enhances production of proinflammatory cytokines and leads to Brucella abortus clearance in mice.

Authors:  Patrícia P Corsetti; Leonardo A de Almeida; Natália B Carvalho; Vasco Azevedo; Teane M A Silva; Henrique C Teixeira; Ana C Faria; Sergio C Oliveira
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.